DIGITAL MATURITY REPORT 2024 / INDUSTRY FOCUS
Digital Maturity in Pharmaceutical
The pharmaceutical industry is transforming with AI, automation, and analytics, driving drug development, efficiency, and patient-centric solutions.
Leaders leverage AI and data-driven strategies to innovate and optimize operations, widening the gap with laggards. This report examines digital maturity, key success factors, and strategies for transformation.
Figure 1: Digital Maturity Index (DMI) Study Results:
Pharmaceutical Industry Score, Averages, Leaders, and Laggards
Digital Maturity Index of Pharmaceutical Industry
While digital transformation is essential, progress remains slow, and industry disparities are growing. This year’s benchmark reveals:
- Minimal digital progress – The industry’s average maturity score increased slightly, reflecting hesitation and regulatory challenges.
- The gap is widening – Leaders now score 3.20, while laggards remain at 2.28, exposing a growing divide in digital capabilities.
- Three key differentiators – Leaders excel in operational efficiency, technology adoption, and workforce development, setting them apart.
The findings are clear: companies that prioritize digital transformation, AI, and workforce upskilling will lead the future of pharmaceuticals.
A Comprehensive Analysis of Digital Maturity in Pharmaceutical Industry
The pharmaceutical industry is evolving rapidly. Will you lead the transformation or struggle to keep up?
Download the Digital Maturity Report 2024: Pharmaceutical Focus now to gain insights on optimizing operations, accelerating innovation, and building a future-ready pharmaceutical ecosystem.
Digital Maturity Report: A Comprehensive Analysis Across Industries and Countries
Discover the pulse of digital transformation with our 2024 Digital Maturity Report, leveraging 621 unique measurements across more than 10 industries and 20 countries to reveal critical trends and opportunities. Elevate your strategic vision—download the report for actionable insights.
